FDEIX
Price
$25.83
Change
-$0.02 (-0.08%)
Updated
Jun 20 closing price
Net Assets
5.1B
VIVAX
Price
$67.64
Change
+$0.12 (+0.18%)
Updated
Jun 20 closing price
Net Assets
188.77B
Interact to see
Advertisement

FDEIX vs VIVAX

Header iconFDEIX vs VIVAX Comparison
Open Charts FDEIX vs VIVAXBanner chart's image
Fidelity Advisor Capital Development I
Price$25.83
Change-$0.02 (-0.08%)
VolumeN/A
Net Assets5.1B
Vanguard Value Index I
Price$67.64
Change+$0.12 (+0.18%)
VolumeN/A
Net Assets188.77B
FDEIX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FDEIX vs. VIVAX commentary
Jun 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDEIX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. FDEIX (5.1B). VIVAX pays higher dividends than FDEIX: VIVAX (2.16) vs FDEIX (0.85). FDEIX was incepted earlier than VIVAX: FDEIX (20 years) vs VIVAX (33 years). FDEIX (0.68) is less costly to investors than VIVAX (0.17). FDEIX is a more actively managed with annual turnover of: 16.00 vs. VIVAX (9.00). FDEIX has a lower initial minimum investment than VIVAX: FDEIX (0) vs VIVAX (3000). FDEIX annual gain was more profitable for investors over the last year : 7.92 vs. VIVAX (6.74). FDEIX return over 5 years is better than : 92.29 vs. VIVAX (70.82).
FDEIXVIVAXFDEIX / VIVAX
Total Expense Ratio0.680.17400%
Annual Report Gross Expense Ratio0.680.17400%
Fund Existence20 years33 years-
Gain YTD7.4402.237333%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.1B189B3%
Annual Yield % from dividends0.852.1640%
Returns for 1 year7.926.74117%
Returns for 3 years55.1032.22171%
Returns for 5 years92.2970.82130%
Returns for 10 years79.53102.0978%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OVID0.310.02
+5.24%
Ovid Therapeutics
TPH30.530.64
+2.14%
Tri Pointe Homes
ULTA473.850.39
+0.08%
Ulta Beauty
OBK34.08-0.59
-1.70%
Origin Bancorp
DSGN3.72-0.07
-1.85%
Design Therapeutics